N Andrew Schiff

Affiliations

  • at Monte Rosa Therapeutics Inc. (GLUE), 2024-06-13
  • at Aclaris Therapeutics Inc. (ACRS), 2024-06-10
  • Large Shareholder at Elevation Oncology Inc. (ELEV), 2023-06-21
  • Large Shareholder at Zosano Pharma Corp (ZSAN), 2019-12-06
  • Large Shareholder at Sunesis Pharmaceuticals Inc (SNSS), 2019-07-15
  • Large Shareholder at Loxo Oncology Inc. (LOXO), 2018-07-12
  • Large Shareholder, Director at Zeltiq Aesthetics Inc (ZLTQ), 2017-05-01
  • Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2016-07-06
  • Large Shareholder at Agile Therapeutics Inc (AGRX), 2016-06-03
  • Large Shareholder at Viewray Inc. (VRAY), 2016-03-30
  • Other at Transenterix Inc. (TRXC), 2016-02-05
  • Large Shareholder at T2 Biosystems Inc. (TTOO), 2015-12-09
  • Large Shareholder at Esperion Therapeutics Inc. (ESPR), 2015-04-27
  • Large Shareholder at Cidara Therapeutics Inc. (CDTX), 2015-04-15
  • Large Shareholder at Versartis Inc. (VSAR), 2015-01-29
  • Large Shareholder at Durata Therapeutics Inc. (DRTX), 2014-05-22
  • Large Shareholder at Adma Biologics Inc. (ADMA), 2013-10-23
  • Large Shareholder at Cempra Inc. (CEMP), 2012-02-09
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ACRS $23.02 108,601 Director 634,455 2017-08-16 Filing
AGRX $6.00 1,333,333 Large Shareholder, Director 2,171,831 2014-05-23 Filing
ZLTQ $13.00 769,231 Large Shareholder, Director 4,172,742 2011-10-24 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ACRS $17.08 1,371 Director 434,455 2022-11-14 Filing
ACRS $17.06 41,160 Director 435,826 2022-11-11 Filing
ACRS $17.02 11,395 Director 476,986 2022-11-10 Filing
ACRS $17.01 14,540 Director 488,381 2022-10-26 Filing
ACRS $17.02 12,018 Director 502,921 2022-10-25 Filing